简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
Global X China Biotech ETF
Global X China Biotech ETF (02820.HK) Rises 3.55% in Afternoon Trade, Latest Price at HKD 68.800
Tags:
Global X China Biotech ETF
ETF
02820.HK
2026-07-10
Global X China Biotech ETF (02820.HK) Rises 4.71% in Morning Trade, Latest NAV at HKD 65.909
Tags:
Global X China Biotech ETF
02820.HK
ETF
2026-07-06
Global X China Biotech ETF (02820.HK) Rises 3.85% in Afternoon Trade, AUM at HKD 607 Million
Tags:
Global X China Biotech ETF
ETF
02820.HK
2026-07-03
Global X China Biotech ETF (02820.HK) Rises 7.54% in Afternoon Trade, AUM at HKD 557 Million
Tags:
Global X China Biotech ETF
ETF
02820.HK
2026-06-29
Global X China Biotech ETF(02820.HK) Rises 0.92% Intraday, Average Traded Price at HK$59.377
Tags:
Global X China Biotech ETF
02820.HK
ETF
2026-06-23
Global X China Biotech ETF (02820.HK) Rises 2.55% in Afternoon Trading as Drug Price Governance Officially Enters New Phase
Tags:
ETF
02820.HK
Global X China Biotech ETF
2026-04-15
Featured News
Finance
Estun (02715.HK): Positive Profit Forecast, Interim Net Profit Attributable to Parent Expected to Surge Around 21 to 26 Times
Finance
CHINA DEVELOPMENT BANK FINANCIAL LEASING(01606.HK): Acquisition of Three Vessels at Consideration Not Exceeding USD 138 Million
Finance
Holly Futures(03678.HK): Independent Director Zhang Hongfa Resigns
Finance
Shenwan Hongyuan (06806.HK): Shenwan Hongyuan Securities Obtains Registration Approval for Perpetual Subordinated Bonds with a Ceiling of RMB 30 Billion
Finance
Luxxu Group(01327.HK): Executive Director Yang Xi Resigns; Liang Yanhuang Appointed as Authorised Representative
Finance
United Laboratories (03933.HK): New Specification of Sodium Hyaluronate Eye Drops Approved for Marketing
Finance
Dongjiang Environmental (00895.HK): 2026 Interim Performance Forecast, Expected Net Loss of RMB 250 Million to RMB 270 Million
Finance
CSPC Pharmaceutical Group (01093.HK): Albumin-Bound Docetaxel Combined with Anitumab Granted Breakthrough Therapy Designation
Finance
China Everbright Water (01857.HK): Completes Issuance of Phase 1 Medium-Term Notes of 2026 with Principal of RMB 1.5 Billion
Finance
MicroTech Medical(02235.HK): Continuous Glucose Monitoring System Secures Marketing Approval in South Korea
Scan QR Code
Download App